Frequently asked questions in the medical manageme... [Ann Oncol. 2008] - PubMed

loading

Management of malignant glioma--quo vadis? [Onkologie. 2008]
Management of malignant glioma--quo vadis?
Stupp R, Hottinger AF. Onkologie. 2008 Jun; 31(6):300-2. Epub 2008 May 27.
Adjuvant temozolomide: how long and how much? [Expert Rev Anticancer Ther. 2008]
Adjuvant temozolomide: how long and how much?
Franceschi E, Tosoni A, Brandes AA. Expert Rev Anticancer Ther. 2008 May; 8(5):663-5.
[Recent advances in the medical treatment of glioma-temozolomide]. [No To Shinkei. 2006]
[Recent advances in the medical treatment of glioma-temozolomide].
Nishikawa R. No To Shinkei. 2006 Dec; 58(12):1035-41.
Review [Glioma therapy up-date]. [Neurologia. 2007]
Review [Glioma therapy up-date].
de la Fuente BP, Dalmau J, Rosenfeld M. Neurologia. 2007 Apr; 22(3):159-69.
Review Optimal role of temozolomide in the treatment of malignant gliomas. [Curr Neurol Neurosci Rep. 2005]
Review Optimal role of temozolomide in the treatment of malignant gliomas.
Stupp R, van den Bent MJ, Hegi ME. Curr Neurol Neurosci Rep. 2005 May; 5(3):198-206.

Review Gene therapy and targeted toxins for glioma. [Curr Gene Ther. 2011]
Review Gene therapy and targeted toxins for glioma.
Castro MG, Candolfi M, Kroeger K, King GD, Curtin JF, Yagiz K, Mineharu Y, Assi H, Wibowo M, Ghulam Muhammad AK, et al. Curr Gene Ther. 2011 Jun; 11(3):155-80.
Review Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics. [Mol Cancer. 2010]
Review Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics.
Krakstad C, Chekenya M. Mol Cancer. 2010 Jun 1; 9:135. Epub 2010 Jun 1.
A novel bicistronic high-capacity gutless adenovirus vector that drives constitutive expression of herpes simplex virus type 1 thymidine kinase and tet-inducible expression of Flt3L for glioma therapeutics. [J Virol. 2010]
A novel bicistronic high-capacity gutless adenovirus vector that drives constitutive expression of herpes simplex virus type 1 thymidine kinase and tet-inducible expression of Flt3L for glioma therapeutics.
Puntel M, Muhammad AK, Candolfi M, Salem A, Yagiz K, Farrokhi C, Kroeger KM, Xiong W, Curtin JF, Liu C, et al. J Virol. 2010 Jun; 84(12):6007-17. Epub 2010 Apr 7.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Frequently asked questions in the medical management of high-grade glioma: a sho...
Frequently asked questions in the medical management of high-grade glioma: a short guide with practical answers.
Ann Oncol. 2008 Sep ;19 Suppl 7:vii209-16.

PubMed
Comparison of baroreceptive to other afferent synaptic transmission to the media...
Comparison of baroreceptive to other afferent synaptic transmission to the medial solitary tract nucleus.
Am J Physiol Heart Circ Physiol. 2008 Nov ;295(5):H2032-42. Epub 2008 Sep 12 .

PubMed
Structural and functional correlates of unilateral mesial temporal lobe spatial ...
Structural and functional correlates of unilateral mesial temporal lobe spatial memory impairment.
Brain. 2008 Nov ;131(Pt 11):3006-18. Epub 2008 Sep 12 .

PubMed
An orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits t...
An orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer.
Mol Cancer Ther. 2008 Sep ;7(9):2725-35.

PubMed
Antixenograft tumor activity of a humanized anti-insulin-like growth factor-I re...
Antixenograft tumor activity of a humanized anti-insulin-like growth factor-I receptor monoclonal antibody is associated with decreased AKT activation and glucose uptake.
Mol Cancer Ther. 2008 Sep ;7(9):2599-608.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed